An N6-methyladenosine and target genes-based study on subtypes and prognosis of lung adenocarcinoma

被引:1
|
作者
Chu, Xiao [1 ]
Wang, Weiqing [1 ]
Sun, Zhaoyun [1 ]
Bao, Feichao [2 ]
Feng, Liang [1 ]
机构
[1] Fudan Univ, Peoples Hosp Shanghai 5, Dept Thorac Surg, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Dept Thorac Surg, Affiliated Chest Hosp, Shanghai, Peoples R China
关键词
N-6-methyladenosine (m(6)A); consensus clustering; prognostic score; immune cells; nomogram; TUMOR; EXPRESSION; CELLS; E2F7;
D O I
10.3934/mbe.2022013
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose: Lung adenocarcinoma (LUAD) is a highly lethal subtype of primary lung cancer with a poor prognosis. N6-methyladenosine (m(6)A), the most predominant form of RNA modification, regulates biological processes and has critical prognostic implications for LUAD. Our study aimed to mine potential target genes of m(6)A regulators to explore their biological significance in subtyping LUAD and predicting survival. Methods: Using gene expression data from TCGA database, candidate target genes of m(6)A were predicted from differentially expressed genes (DEGs) in tumor based on M(6)A2 Target database. The survival-related target DEGs identified by Cox-regression analysis was used for consensus clustering analysis to subtype LUAD. Uni-and multi-variable Cox regression analysis and LASSO Cox-PH regression analysis were used to select the optimal prognostic genes for constructing prognostic score (PS) model. Nomogram encompassing PS score and independent prognostic factors was built to predict 3-year and 5-year survival probability. Results: We obtained 2429 DEGs in tumor tissue, within which, 1267 were predicted to m(6)A target genes. A prognostic m(6)A-DEGs network of 224 survival-related target DEGs was established. We classified LUAD into 2 subtypes, which were significantly different in OS time, clinicopathological characteristics, and fractions of 12 immune cell types. A PS model of five genes (C1QTNF6, THSD1, GRIK2, E2F7 and SLCO1B3) successfully split the training set or an independent GEO dataset into two subgroups with significantly different OS time (p < 0.001, AUC = 0.723; p = 0.017, AUC = 0.705).A nomogram model combining PS status, pathologic stage, and recurrence was built, showing good performance in predicting 3-year and 5-year survival probability (C-index = 0.708, 0.723, p-value = 0). Conclusion: Using candidate m(6)A target genes, we obtained two molecular subtypes and designed a reliable five-gene PS score model for survival prediction in LUAD.
引用
收藏
页码:253 / 270
页数:18
相关论文
共 50 条
  • [1] Target genes of N6-methyladenosine regulatory protein ALKBH5 are associated with prognosis of patients with lung adenocarcinoma
    Jiang, Long
    Lan, Lan
    Qiu, Yuan
    Lu, Weixiang
    Wang, Wenjun
    Huang, Ying
    JOURNAL OF THORACIC DISEASE, 2023, 15 (06) : 3228 - +
  • [2] Genomics and Prognosis Analysis of N6-Methyladenosine Regulators in Lung Adenocarcinoma
    Ma, Yanpin
    Zhang, Huping
    FRONTIERS IN GENETICS, 2021, 12
  • [3] The N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma
    Wang, Shiyan
    Zeng, Yong
    Zhu, Lin
    Zhang, Min
    Zhou, Lei
    Yang, Weixiong
    Luo, Weishan
    Wang, Lina
    Liu, Yanming
    Zhu, Helen
    Xu, Xin
    Su, Peiran
    Zhang, Xinyue
    Ahmed, Musaddeque
    Chen, Wei
    Chen, Moliang
    Chen, Sujun
    Slobodyanyuk, Mykhaylo
    Xie, Zhongpeng
    Guan, Jiansheng
    Zhang, Wen
    Khan, Aafaque Ahmad
    Sakashita, Shingo
    Liu, Ni
    Pham, Nhu-An
    Boutros, Paul C.
    Ke, Zunfu
    Moran, Michael F.
    Cai, Zongwei
    Cheng, Chao
    Yu, Jun
    Tsao, Ming S.
    He, Housheng H.
    CANCER DISCOVERY, 2024, 14 (11) : 2279 - 2299
  • [4] Genes related to N6-methyladenosine in the diagnosis and prognosis of idiopathic pulmonary fibrosis
    Zhang, Jingcheng
    Zhang, Ying
    Wang, Ziyuan
    Zhao, Jiachao
    Li, Zhenyu
    Wang, Keju
    Tian, Lin
    Yao, Baojin
    Wu, Qibiao
    Wang, Tan
    Wang, Jing
    FRONTIERS IN GENETICS, 2023, 13
  • [5] N6-methyladenosine methylation of viral genes
    Sun, Jiting
    Zhang, Yan
    Luo, Bing
    FUTURE VIROLOGY, 2023, 18 (12) : 809 - 821
  • [6] The YTH Domain Family of N6-Methyladenosine "Readers" in the Diagnosis and Prognosis of Colonic Adenocarcinoma
    Xu, Dian
    Shao, Jun
    Song, Huan
    Wang, Jianming
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [7] The prognostic value of N6-methyladenosine RBM15 regulators in lung adenocarcinoma
    Ma, Mingsheng
    Wang, Wei
    Wang, Biying
    Yang, Yichen
    Huang, Yunchao
    Zhao, Guangqiang
    Ye, Lianhua
    CELLULAR AND MOLECULAR BIOLOGY, 2022, 68 (01) : 130 - 139
  • [8] Analysis of N6-Methyladenosine Methylome in Adenocarcinoma of Esophagogastric Junction
    Huang, Jia-Bin
    Hu, Bin-Bin
    He, Rong
    He, Lian
    Zou, Chen
    Man, Chang-Feng
    Fan, Yu
    FRONTIERS IN GENETICS, 2022, 12
  • [9] The momentous role of N6-methyladenosine in lung cancer
    Xu, Ruiyao
    Pang, Gaozong
    Zhao, Qing
    Yang, Lin
    Chen, Shu
    Jiang, Long
    Shen, Yuxian
    Shao, Wei
    JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (05) : 3244 - 3256
  • [10] Identifying subtypes and developing prognostic models based on N6-methyladenosine and immune microenvironment related genes in breast cancer
    Wang, Lizhao
    Li, Jianpeng
    Mei, Nan
    Chen, Heyan
    Niu, Ligang
    He, Jianjun
    Wang, Ru
    SCIENTIFIC REPORTS, 2024, 14 (01):